a clinical stage orthobiologics company dedicated to the development
of novel therapeutic soft tissue repair technologies to dramatically
improve the success rate of orthopedic and sports medicine surgeries
ORTHO is in the regulatory lead for regenerative products
fast facts
- name Ortho Regenerative Technologies Inc.
- symbol ORTH
- exchange CSE
- financials View Filings
- shares outstanding 51,038,776 as of 04/30/2022
- industry Technology & Medical
- transfer agent Computershare Investor Services Inc.
- website http://www.orthorti.com
recent updates
most recent messages
top rated messages